Neil Singla

APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of…

Pain Practice · 2019 · First of 7 authors · 153 citations

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of…

Journal of Pain Research · 2019 · Last of 6 authors · 139 citations